LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (LXRX)

CUSIP: 528872302

Q1 2024 13F Holders as of 31 Mar 2024

Holder snapshot 7 signals
Share change
-11,073,000
Put/Call ratio
20%
SEC-reported price per share
$2.40
Number of holders
114
Value change
-$24,970,122
Number of buys
59
Open additional details 1 more signal available
Number of sells
51
Security identity Names, identifiers, and filing context for this profile. 1 source field
Shares outstanding
442,581,578

Security key

528872302

Report period

Q1 2024

Institutions

114

Top holders

10

Ownership snapshot

Top reported holders of LXRX - LEXICON PHARMACEUTICALS, INC. - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader
Invus US Partners LLC
Disclosed value leader
Artal Group S.A.
Comparable rows
0/15
Latest evidence
28 Feb 2024
3/4/5 13F Highest disclosed value: $179,857,000 15 rows are not safely comparable across share classes. Showing 1-6 of 15 holder rows.

Quick read

Artal Group S.A. has the largest disclosed position value at $179.86M.

0 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Artal Group S.A.'s linked filing trail.
Disclosed position value Top 5
Invus US Partners LLC $6.09M
Artal Group S.A. $179.86M
BVF INC/IL $37.39M
BlackRock Finance, Inc. $10.72M
VANGUARD GROUP INC $9.15M

Value bars compare disclosed positions; verify each figure against the linked filing evidence.

Detailed SEC evidence table Showing 1-6 of 15 holder rows
Holder Evidence Ownership % Position 12M Net Δ As of
Invus US Partners LLC
3/4/5
Director, 10%+ Owner
—
denominator unverified
$6,090,969
5,782,749 shares
— 05 Aug 2022
Artal Group S.A.
13F
Company
13F
—
denominator unverified
$179,857,000
117,553,284 shares
— 31 Dec 2023
BVF INC/IL
13F
Company
13F
—
denominator unverified
$37,386,517
24,435,632 shares
— 31 Dec 2023
BlackRock Finance, Inc.
13F
Company
13F
—
denominator unverified
$10,717,885
7,005,153 shares
— 31 Dec 2023
VANGUARD GROUP INC
13F
Company
13F
—
denominator unverified
$9,149,968
5,980,371 shares
— 31 Dec 2023
JPMORGAN CHASE & CO
13F
Company
13F
—
denominator unverified
$4,656,235
3,043,291 shares
— 31 Dec 2023
How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q1 2024

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions
114
Shares
171,815,966
Rows available
114
Investor Option Weight % Change % SEC-reported value * Price Shares Share Change Activity Report Period

* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q1 2024 vs Q1 2024 Across Filers

Q1 2024 holders
114
Q1 2024 holders
114
Holder diff
0
Investor Q1 2024 Shares Q1 2024 Shares Share Diff Share Chg % Q1 2024 value Q1 2024 value Value change Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .